Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia

Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension

(2018) Andrew J. Bryant et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis

(2018) Martin Kolb et al.   NEW ENGLAND JOURNAL OF MEDICINE

RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis

(2016) Marina Lesina et al.   JOURNAL OF CLINICAL INVESTIGATION

Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

(2015) Vanessa J. Craig et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension

(2015) X.M. Wang et al.   GENETICS AND MOLECULAR RESEARCH

Expression of Mutant Bone Morphogenetic Protein Receptor II Worsens Pulmonary Hypertension Secondary to Pulmonary Fibrosis

(2015) Andrew J. Bryant et al.   Pulmonary Circulation

Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis

(2014) Wenhong Wang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Evidence for Right Ventricular Lipotoxicity in Heritable Pulmonary Arterial Hypertension

(2013) Anna R. Hemnes et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis

(2013) Hiroshi Katoh et al.   CANCER CELL

Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis

(2013) Belinda N. Rivera-Lebron et al.   CHEST

Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways

(2013) Makito Miyake et al.   LABORATORY INVESTIGATION

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects

(2012) Jose Gomez-Arroyo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

(2011) Talmadge E. King et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis

(2011) Thomas J. Richards et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary Hypertension

(2011) Michael E. Yeager et al.   CHEST

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis

(2011) Eoin P. Judge et al.   EUROPEAN RESPIRATORY JOURNAL

Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function

(2010) V. J. Burton et al.   BLOOD

A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells

(2009) Eliana Ribechini et al.   EUROPEAN JOURNAL OF IMMUNOLOGY